"I don't believe for one moment that what's going on here is an honest investigation of whether these products should be compounded." contributed to this report.
Research on GHK-Cu for skin in women (including both clinical trials measuring skin density and dermatological studies on photoaging) consistently show meaningful results at the 12 mg/day injectable dose range or equivalent topical coverage
BPC-157's angiogenic properties and growth factor modulation may support healthier tissue adaptation during this process, though this remains an area of clinical observation rather than confirmed trial data
That is the core promise of Dihexa, one of the most potent and intriguing experimental neuropeptides to emerge from academic research in recent years
Breathing issues at night, restless legs, pain, and mood can all sway the result
The peptide also activates the FAK-paxillin pathway, important for cellular adhesion, migration, proliferation, and survival